share_log

信邦制药(002390.SZ):旗下医院有淋巴细胞亚群、淋巴细胞活化、树突状细胞、细胞凋亡及白血病免疫分析等检测业务

Guizhou Xinbang Pharmaceutical (002390.SZ): Its hospital offers testing services such as lymphocyte subgroups, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immune analysis.

Gelonghui Finance ·  Sep 20 15:45

Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that its hospitals have testing services for lymphocyte subsets, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immunological analysis.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment